The global specialty pharmaceuticals market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth in this market is attributed to the increasing demand for specialty drugs and the growing number of patients with chronic diseases. The major drivers for this market are increasing prevalence of chronic diseases, rising healthcare expenditure, and technological advancements in drug development.
The global specialty pharmaceuticals market by type is segmented into oral pharmaceuticals, parenteral pharmaceuticals, and transdermal pharmaceuticals. Oral pharmaceuticals accounted for the largest share in 2018 due to their wide range of applications such as treatment of diabetes mellitus type 2 (DM2), hypertension (HTN), hyperlipidemia (HLP), osteoporosis (OP) etc, which are all chronic conditions that require long-term treatment with medications. Parenteral Pharmaceuticals accounted for a small share in 2018 due to their limited application scope such as administration through injection or infusion into a vein or artery; however they have been gaining traction over time owing to their high efficacy rates and low side effects when compared with oral drugs.
Some Of The Growth Factors Of This Market:
- The aging population is a key factor in the growth of the specialty pharmaceutical market.
- The increase in chronic diseases and the need for more personalized treatments are also driving factors in this market's growth.
- The increasing number of people with high-deductible health plans is also a factor, as these plans often require patients to pay for expensive drugs out-of-pocket, which can be prohibitively expensive for many people without adequate insurance coverage or financial resources to cover such costs on their own.
- Increasing demand from emerging markets is another factor that will contribute to the growth of this market over time, as these countries are experiencing rapid economic development and an increased standard of living that has led to an increased demand for specialty pharmaceuticals among their populations who have previously been unable to afford them due to their high cost relative to income levels in those countries; this trend will likely continue as these economies continue developing and incomes rise accordingly over time, leading more people there being able to afford specialty pharmaceuticals and thus driving up demand for them globally over time as well.
- Finally, technological advances are also contributing factors in the growth of this market; new technologies such as gene therapy have opened up new avenues for treatment that were not previously available before and thus contributed significantly towards its expansion by making it possible for more patients than ever before who would not otherwise be able or willing able or willing able or willing able or willing able or willing able or unwilling unable.
Industry Growth Insights published a new data on “Specialty Pharmaceuticals Market”. The research report is titled “Specialty Pharmaceuticals Market research by Types (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), By Applications (Hospitals, Retail Pharmacies, Specialty Pharmacies, Mail Order), By Players/Companies Teva Pharmaceuticals, Abbvie, Amgen, Johnson & Johnson, Celgene, Gilead Sciences, Roche”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Specialty Pharmaceuticals Market Research Report
By Type
Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals
By Application
Hospitals, Retail Pharmacies, Specialty Pharmacies, Mail Order
By Companies
Teva Pharmaceuticals, Abbvie, Amgen, Johnson & Johnson, Celgene, Gilead Sciences, Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Specialty Pharmaceuticals Market Report Segments:
The global Specialty Pharmaceuticals market is segmented on the basis of:
Types
Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Retail Pharmacies, Specialty Pharmacies, Mail Order
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceuticals
- Abbvie
- Amgen
- Johnson & Johnson
- Celgene
- Gilead Sciences
- Roche
Highlights of The Specialty Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Pharmaceuticals
- Parenteral Pharmaceuticals
- Transdermal Pharmaceuticals
- By Application:
- Hospitals
- Retail Pharmacies
- Specialty Pharmacies
- Mail Order
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Specialty Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Specialty Pharmaceuticals is a company that manufactures and markets prescription drugs. It was founded in 1984 and has since grown to be one of the largest pharmaceutical companies in the world. Specialty Pharmaceuticals' products include medications for cancer, heart disease, diabetes, and other serious medical conditions.
Some of the key players operating in the specialty pharmaceuticals market are Teva Pharmaceuticals, Abbvie, Amgen, Johnson & Johnson, Celgene, Gilead Sciences, Roche.
The specialty pharmaceuticals market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Specialty Pharmaceuticals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Specialty Pharmaceuticals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Specialty Pharmaceuticals Market - Supply Chain
4.5. Global Specialty Pharmaceuticals Market Forecast
4.5.1. Specialty Pharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Specialty Pharmaceuticals Market Size (000 Units) and Y-o-Y Growth
4.5.3. Specialty Pharmaceuticals Market Absolute $ Opportunity
5. Global Specialty Pharmaceuticals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Specialty Pharmaceuticals Market Size and Volume Forecast by Type
5.3.1. Oral Pharmaceuticals
5.3.2. Parenteral Pharmaceuticals
5.3.3. Transdermal Pharmaceuticals
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Specialty Pharmaceuticals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Specialty Pharmaceuticals Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Retail Pharmacies
6.3.3. Specialty Pharmacies
6.3.4. Mail Order
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Specialty Pharmaceuticals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Specialty Pharmaceuticals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Specialty Pharmaceuticals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Specialty Pharmaceuticals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Specialty Pharmaceuticals Demand Share Forecast, 2019-2026
9. North America Specialty Pharmaceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Specialty Pharmaceuticals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Specialty Pharmaceuticals Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Retail Pharmacies
9.4.3. Specialty Pharmacies
9.4.4. Mail Order
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Specialty Pharmaceuticals Market Size and Volume Forecast by Type
9.7.1. Oral Pharmaceuticals
9.7.2. Parenteral Pharmaceuticals
9.7.3. Transdermal Pharmaceuticals
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Specialty Pharmaceuticals Demand Share Forecast, 2019-2026
10. Latin America Specialty Pharmaceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Specialty Pharmaceuticals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Specialty Pharmaceuticals Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Retail Pharmacies
10.4.3. Specialty Pharmacies
10.4.4. Mail Order
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Specialty Pharmaceuticals Market Size and Volume Forecast by Type
10.7.1. Oral Pharmaceuticals
10.7.2. Parenteral Pharmaceuticals
10.7.3. Transdermal Pharmaceuticals
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Specialty Pharmaceuticals Demand Share Forecast, 2019-2026
11. Europe Specialty Pharmaceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Specialty Pharmaceuticals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Specialty Pharmaceuticals Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Retail Pharmacies
11.4.3. Specialty Pharmacies
11.4.4. Mail Order
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Specialty Pharmaceuticals Market Size and Volume Forecast by Type
11.7.1. Oral Pharmaceuticals
11.7.2. Parenteral Pharmaceuticals
11.7.3. Transdermal Pharmaceuticals
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Specialty Pharmaceuticals Demand Share, 2019-2026
12. Asia Pacific Specialty Pharmaceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Specialty Pharmaceuticals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Specialty Pharmaceuticals Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Retail Pharmacies
12.4.3. Specialty Pharmacies
12.4.4. Mail Order
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Specialty Pharmaceuticals Market Size and Volume Forecast by Type
12.7.1. Oral Pharmaceuticals
12.7.2. Parenteral Pharmaceuticals
12.7.3. Transdermal Pharmaceuticals
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Specialty Pharmaceuticals Demand Share, 2019-2026
13. Middle East & Africa Specialty Pharmaceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Specialty Pharmaceuticals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Specialty Pharmaceuticals Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Retail Pharmacies
13.4.3. Specialty Pharmacies
13.4.4. Mail Order
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Specialty Pharmaceuticals Market Size and Volume Forecast by Type
13.7.1. Oral Pharmaceuticals
13.7.2. Parenteral Pharmaceuticals
13.7.3. Transdermal Pharmaceuticals
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Specialty Pharmaceuticals Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Specialty Pharmaceuticals Market: Market Share Analysis
14.2. Specialty Pharmaceuticals Distributors and Customers
14.3. Specialty Pharmaceuticals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbvie
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Amgen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Johnson & Johnson
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Celgene
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Gilead Sciences
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
